PTN_OUT_1 [2025-03-25 08:18:28 -0400] 2014 Bytes | 566 tokens | Cum: 566 tkns (7.07% of 8k)
==========================================================================

Booyah, my friends! It's already 8:18:27 AM on Tue Mar 25, 2025 -0400, and I've got my eyes locked on Palatin Technologies (PTN), pushing up to 0.96 from 0.7529. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

Here's the first list of news for Palatin Technologies:

C1 - Today 07:30AM - Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency
C2 - Mar-13-25 09:55AM - Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now
C3 - Feb-14-25 03:20AM - Q2 2025 Palatin Technologies Inc Earnings Call
C4 - Feb-14-25 03:20AM 02:18AM - Palatin Technologies Inc (PTN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ...
C5 - Feb-13-25 07:30AM - Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
C6 - Feb-10-25 04:00PM - Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025
C7 - Feb-07-25 08:00AM - Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
C8 - Feb-07-25 08:00AM 07:01AM - Palatin concludes Phase II trial of combination therapy for obesity

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Palatin Technologies (PTN)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

PTN_OUT_3 [2025-03-25 08:18:30 -0400] 1038 Bytes | 286 tokens | Cum: 854 tkns (10.67% of 8k)
==========================================================================

Showing C1 (chunk 1 of 9): C1:
**Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency**
Date: Today 07:30AM
Source: (PR Newswire)
URL: https://www.prnewswire.com/news-releases/palatins-oral-mc4r-agonist-pl7737-receives-fda-orphan-drug-designation-for-obesity-due-to-leptin-receptor-deficiency-302409657.html

CRANBURY, N.J.,March 25, 2025/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the US Food & Drug Administration (FDA) has granted "orphan drug" designation to PL7737, an oral treatment that activates the melanocortin-4 receptor, for leptin receptor (LEPR) deficiency, including obesity caused by this condition.

"This FDA orphan designation is a key step in developing Pala

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

PTN_OUT_5 [2025-03-25 08:18:32 -0400] 585 Bytes | 155 tokens | Cum: 1011 tkns (12.64% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-25T12:06:00Z - Palatin Technologies Announces FDA Orphan Designation For PL7737...
A2 - 2025-03-25T11:45:34Z - Palatin Technologies Announces FDA Orphan Designation For PL7737 - Quick Facts...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

PTN_OUT_7 [2025-03-25 08:18:39 -0400] 1038 Bytes | 273 tokens | Cum: 1286 tkns (16.07% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Palatin Technologies Announces FDA Orphan Designation For PL7737**Date: 2025-03-25Source: {'uri': 'finanznachrichten.de', 'dataType': 'news', 'title': 'FinanzNachrichten.de'}URL: https://www.finanznachrichten.de/nachrichten-2025-03/64920479-palatin-technologies-announces-fda-orphan-designation-for-pl7737-020.htmWASHINGTON (dpa-AFX) - Palatin Technologies (PTN) announced the FDA has granted orphan drug designation to PL7737, an oral treatment that activates the melanocortin-4 receptor, for leptin receptor deficiency, including obesity caused by this condition.

Carl Spana, President and CEO of Palatin, said: 'Currently, the only FDA-approved treatment for obesity due to leptin receptor deficiency is a daily injection. PL7737's oral form could provide a more convenient and effective option for these patients and others with rare genetic obesity disorders. We are also exploring PL7737

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

PTN_OUT_9 [2025-03-25 08:18:40 -0400] 973 Bytes | 304 tokens | Cum: 1711 tkns (21.39% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-02-09T21:40:00Z - Data la crescita esponenziale del settore del turismo in Arabia Saudita, dmg events annuncia il salone Hotel & Hospitality Expo
B2 - 2025-02-07T06:38:00Z - As Saudi Arabia’s Tourism Sector Grows Exponentially, dmg events Announces Hotel & Hospitality Expo
B3 - 2024-05-20T16:00:08Z - Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?
B4 - 2024-04-12T12:36:12Z - Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
B5 - 2024-04-09T12:59:00Z - Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
B6 - 2024-02-28T19:02:02Z - Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

PTN_OUT_11 [2025-03-25 08:18:43 -0400] 536 Bytes | 148 tokens | Cum: 1861 tkns (23.26% of 8k)
==========================================================================

Showing B3 (chunk 1 of 1): B3:
**Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2276232/palatin-technologies-ptn-upgraded-to-buy-what-does-it-mean-for-the-stockPalatin Technologies (PTN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

PTN_OUT_13 [2025-03-25 08:18:45 -0400] 1091 Bytes | 326 tokens | Cum: 2230 tkns (27.88% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-02-13 10-Q PART I FIN INFO

Item 1. Fin Stmnts.

PALATIN TECHNOLOGIES, INC .

and Subsidiary

Cons Balance Sheets

(unaudited)

December 31, 2024

June 30, 2024

ASSETS

Curr assets:

Cash and cash equiv

$ 3,416,604

$ 9,527,396

Prepaid e...

S2 - 2025-02-11 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On February 11, 2025, Palatin Technologies, Inc. (the Company) entered into an At the Market Issuance Sales Agrmt (the Sales Agrmt), with A.G.P./Alliance Global Partners (A.G.P.), pursuant to which the Company may, f...

S3 - 2025-02-10 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On February 6, 2025, Palatin Technologies, Inc. (the Company) entered into a securities purchase agreement (the Purchase Agrmt) with an institutional investor, to sell in a registered direct offering (the RD Offering), a...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

PTN_OUT_15 [2025-03-25 08:18:46 -0400] 1038 Bytes | 319 tokens | Cum: 2551 tkns (31.89% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
PART I FINANCIAL INFORMATION

Item 1. Financial Statements.

PALATIN TECHNOLOGIES, INC .

and Subsidiary

Consolidated Balance Sheets

(unaudited)

December 31, 2024

June 30, 2024

ASSETS

Current assets:

Cash and cash equivalents

$ 3,416,604

$ 9,527,396

Prepaid expenses and other current assets

253,113

242,272

Total current assets

3,669,717

9,769,668

Property and equipment, net

235,741

388,361

Right-of-use assets - operating leases

347,644

527,321

Other assets

56,916

56,916

Total assets

$ 4,310,018

$ 10,742,266

LIABILITIES AND STOCKHOLDERS DEFICIENCY

Current liabilities:

Accounts payable

$ 6,718,233

$ 4,101,929

Accrued expenses

1,650,700

4,185,046

Short-term operating lease liabilities

257,673

380,542

Short-term finance lease liabilities

-

46,014

Other current liabilities

932,150

944,150

Total current liabiliti

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

PTN_OUT_17 [2025-03-25 08:18:54 -0400] 1038 Bytes | 322 tokens | Cum: 2875 tkns (35.94% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): es

9,558,756

9,657,681

Long-term operating lease liabilities

100,071

163,782

Other long-term liabilities

1,032,300

1,032,300

Total liabilities

10,691,127

10,853,763

Commitments and contingencies (Note 12)

Stockholders deficiency:

Preferred stock of $ 0.01 par value authorized 10,000,000 shares: shares issued and outstanding designated as follows:

Series A Convertible: authorized 4,030 shares as of December 31, 2024: issued and outstanding 4,030 shares as of December 31, 2024 and June 30, 2024

40

40

Common stock of $ 0.01 par value authorized 300,000,000 shares:

issued and outstanding 23,455,846 shares as of December 31, 2024 and 17,926,640 shares as of June 30, 2024

234,558

179,266

Additional paid-in capital

445,416,974

441,475,747

Accumulated deficit

( 452,032,681 )

( 441,766,550 ) Total stockholders deficiency

( 6,381,109 )

( 111,497 ) Total

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

PTN_OUT_19 [2025-03-25 08:19:10 -0400] 4267 Bytes | 1213 tokens | Cum: 4246 tkns (53.08% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+
| Volume: 277,122 | SMA50: -18.21% | Market Cap: 19.58M | Option/Short: Yes / Yes | Sales past 5Y: 148.40% | Sales Surprise: - |
+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+
| Avg Volume: 820.87K | SMA200: -38.94% | Shs Outstand: 26.01M | Short Float: 5.89% | Employees: 30 | EPS Surprise: 71.43% |
+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+
| Rel Volume: 0.33 | Perf Week: -7.06% | Shs Float: 25.24M | Short Ratio: 1.81 | Debt/Eq: - | P/E: - |
+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+
| RSI (14): 38.38 | Perf Month: -24.71% | Inst Own: 14.19% | Short Interest: 1.49M | Sales Y/Y TTM: -95.07% | Earnings: Feb 13 BMO |
+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+
| ATR (14): 0.08 | Perf Quarter: 0.39% | Insider Own: 2.93% | Beta: 0.79 | ROE: -269476.55% | |
+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+
| SMA20: -8.61% | Index: - | Insider Trans: 0.00% | Sales Q/Q: -100.00% | ROI: - | |
+---------------------+---------------------+----------------------+-------------------------+------------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: Palatin Technologies, Inc.
Market Cap: 19579801.4534
Shares Outstanding: 26005846
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 1809371.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -26952211.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.7529
Average Volume: 371709.81
30-Day High: 0.9797
30-Day Low: 0.7529

[Detailed Financials: Q2 2025]
- Total Assets: $4,310,018.0
- Total Liabilities: $10,691,127.0
- Total Equity: $-6,381,109.0
- Current Assets: $3,669,717.0
- Current Liabilities: $9,558,756.0

[Income Statement: Q2 2025]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.12

[Cash Flow Statement: Q2 2025]
- Net Cash Flow: $-6,110,792.0

[Detailed Financials: Q1 2025]
- Total Assets: $3,415,259.0
- Total Liabilities: $11,100,864.0
- Total Equity: $-7,685,605.0
- Current Assets: $2,612,649.0
- Current Liabilities: $9,861,717.0

[Income Statement: Q1 2025]
- Revenue: $1,459,371.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.39

[Cash Flow Statement: Q1 2025]
- Net Cash Flow: $0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

PTN_OUT_21 [2025-03-25 08:19:12 -0400] 676 Bytes | 167 tokens | Cum: 4682 tkns (58.53% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

PTN_IN_23 [2025-03-25 08:19:13 -0400] 126 Bytes | 29 tokens | Cum: 4739 tkns (59.24% of 8k)
==========================================================================

====================================
[2025-03-25 05:19:13] # Analysis Completed
Elapsed Time: 46.59 seconds